Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DrBP should be running this shit show... NP way over his head here...
Reduction of viral load is one of the three benefits of leronlimab.
Did NP even watch the DrBP TedX?
I hope he escalates that accusation... it’s getting ridiculous.
I see another Senate hearing grilling Fauci again if so.
NP needs surrogates to push leronlimab info to the public... or a petition.
Will NP make the response public? Doubtful...
Agreed, but it’s just not how people work. They’d rather take a pill than change their lifestyle.
As easy as LL is to administer, yes I believe it could be a prophylactic for high risk workers (hospitals).
Leronlimab could easily put Covid in the trash bin but cydy is not good at getting its message out.
If we don’t want to sell then we’re racing the vaccines.
That needs to be the public message. A outpatient shot from home and feel better in three days. Which is nothing for a long hauler.
When it hits big names like Dr. Drew and he backs it then you’ll have some traction with the public and the media will ask about it more.
Right now BP is just trying to focus on vaccines. A working therapeutic cuts into that $$ big time. People would rather be reactive than proactive. Especially if they rushed the vaccine. LL has a long proven safety record, this is a huge threat to their business and NP isn’t selling.
Agreed... let’s hope his replacement is someone who can tame NP
That is to be seen... but would be nice.
BOD member retired at this critical juncture? That’s telling. Hopefully science over stupidity plays out.
Yep, it’ll be up to DrBP and others to get leronlimab to market.
If they do then NP will take credit for it I’m sure.
The only thing holding leronlimab back is NP, IMO.
It’s funny they’ll talk about this but not leronlimab
https://www.cbsnews.com/news/trump-oleandrin-covid-treatment-toxic-plant/
Dr Yo, Dr Drew and Dr BP on YouTube soon to discuss leronlimab.
That’s a start in the right direction.
Lol... you’re not the official DD judge here. You don’t like the discussion then block me.
I think someone else here said that the current BOD just follows NPs lead. I sure hope not, they are paid for their opinions not their allegiance.
Too each his own, some say NP wasn’t responsible for Pro-140 acquisition.
When I lead a team I make sure those that contribute are recognized and compensated. NP history seems to tell a different story.
The science is strong here... but NP can screw it up.
No 10k? Not even an NT?
NP is insecure... like most of his personality profile friends. You can tell by his actions.
1. Taking credit for others work
2. Being overly sensitive to short attacks
3. Wanting complete control of the BOD and business direction.
Starting to believe BPat and NP aren’t on the same page.
BOD needs to grow a set.
It does, NP is wrong again.
Clinical trials should validate the news, not vice versa.
SP suffers as it’s unknown and NPs history while questionable is enough to hold back retail. Bad optics.
NP has never brought a drug to market and it’s not his background.
Bad time to have a rookie CEO and no plan. Even Dr. Yo said the only thing holding back leronlimab is a plan to execute.
It’s not been approved yet.
Yeah, it does. If it’s under $3 or $4 it’s not going to happen.
NP has thrown all of his ammo at this... won’t work until the FDA approves or accepts something.
Repeats, they keep pumping old info.
Only need 100k signatures in a petition to the WH to force a response.
Dr Yo said all leronlimab needs is a plan to market. Odd he would say that, almost as if there isn’t one.
Both... but at the end of the day it’s the shareholders who suffer.
Yeah, I know aviptadil and they have blown past CYDY. https://bgr.com/2020/08/03/coronavirus-cure-rlf-100-aviptadil-phase-3-trial/
If NP can’t close a slam dunk like Covid then I doubt he’ll be CEO much longer.
They still have no info on leronlimab lol...
NP have someone call these idiots...
https://finance.yahoo.com/news/coronavirus-update-europe-uk-strike-vaccine-deals-antibody-therapies-on-the-rise-165032480.html
Good point, at first I thought Covid would be the first possible revs.. however with the FDA moving incredibly slow the HIV BLA may come sooner.
America (Red states) is waking up to the over dramatized fear of Covid and going back to normal life. That makes trials harder to fill and the need for a cure less important. That means BP can wait for a halfass vaccine and get their $$. Leaving the small MABs to die again. Those small mabs who “playball” like HGEN can get a small market share. NP will likely get shutout if he stays arrogant.
The BOD sucks if they can’t see this. The new people signing onto the science officer board will have to see this and call BS or they’ll quit. They won’t waste their time with this guy.
It’s funny how NP says he is humble and he saved the company all in one breath.
AF/Stat would have nothing to harp on if NP wasn’t around.
At first I thought his golden parachute re-nup was in case of a buyout. Now I think it’s because he’s being threatened for dismissal and he now holds this as financial leverage over the BOD.
Need Covid revs to get HIV to market, otherwise more dilution and risk.
What’s the risk of selling leronlimab to third world countries without FDA EUA?
They opt for the SOC. Why die unnecessarily? Have to go to countries where the SOC is worse, like HGEN did. Smart...
https://english.aawsat.com/home/article/2451351/saudi-arabia-using-ecmo-technology-treat-covid-19-patients
Looks like they need some Leron....
NP holds the key to world recovery...
My HGEN buy is a bet on the FDA to go with BP favorites and not the untamable CYDY.
From the personal stories I have Covid presents the same in the 80+ elderly. But it hits them harder psychologically. Alzheimer patients tend to give up as they don’t understand what’s happening.
If NP stays silent and lets the FDA do the talking it could start to rise again to $10 as before.
Apparently the market hates it when NP talks.
2000 screams a fear of statistical insignificance.
Apparently not
Trump news presser tonight. What are the odds it’s a leronlimab announcement now that the EUA request is in with competition.
That would be nice and appreciated
I gave more CYDY than HGEN 10:1
If FDA does not react positively to CYDY within next month then I’ll shift to hgen more.
CYDY has the better drug, but remdesivir has proven that they can peddle crap very easily.